Patient Education in Osteoporosis (RCT-PATOS)
- Sponsor
- University Hospital, Linkoeping
- Study ID
- NCT07367776
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Digital patient education — BEHAVIORALAn internet-based program comprising nine modules will be available to participants for a duration of one year. The program addresses essential components of patient education in osteoporosis and includes a variety of learning formats such as text, images, videos, reflection exercises, knowledge-check questions, and checklists. The estimated total time required to complete the program is approximately 5.5 hours. Intervention adherence will be monitored. For the digital intervention, adherence will be assessed by number of modules accessed.
- Face-to-face patient education — BEHAVIORALThree theoretical sessions, each lasting two hours, will be conducted over a period of 3-5 weeks. The sessions adhere to a standardized curriculum addressing key aspects of osteoporosis management. Two sessions will be led by physiotherapists, and one session by either a physician or a nurse. Each group will include a maximum of 15 participants. Intervention adherence will be monitored. For the group-based intervention, attendance at scheduled sessions will be recorded.
- General information on osteoporosis (open website) — BEHAVIORALParticipants receive general osteoporosis information provided by healthcare services (open website with general information on osteoporosis: https://www.1177.se/sjukdomar--besvar/skelett-leder-och-muskler/benskorhet---osteoporos/ ).
Study Details
The objective of this randomized clinical trial is to assess both the effectiveness and underlying mechanisms of patient education for individuals aged 50 years and older with osteoporosis. Primary research question: What differences in outcomes can be observed among three different educational interventions with respect to osteoporosis-specific self-care, health related quality of life, fracture risk, illness perception, physical activity, physical function, fear of falling, and pain in patients diagnosed with osteoporosis? The trial will include three study arms: 1) Control group: Participants receive standard osteoporosis information provided by healthcare services. 2) Face-to-face education: Three 2-hours sessions led by a physiotherapist (two sessions) and physician or nurse (one session) within a 2 months period. 3) Digital education: Internet-based program consisting of nine modules accessible to participants over a one-year period. Participants will complete questionnaires and undergo physical assessments at baseline, and at 3 and 12 months follow up. Additionally, a subset of participants will undergo objective assessment of physical activity pattern and sedentary behaviours with an accelerometer at baseline and after 3 and 12 months.
Key Dates
- Start date
- Jan 27, 2026
- Status verified
- Mar 2026
- Primary completion
- Oct 20, 2028
- Completion
- Oct 20, 2028
Study Design
- Enrollment
- 600 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Active Comparator: Usual care (Control)General information on osteoporosis (open website)
- Active Comparator: Face-to-face patient educationStructured group-based theoretical education ('osteoporosis school')
- Active Comparator: Digital patient educationInternet-based patient education program
Primary Outcome Measure
Osteoporosis specific self-care - OsCare Questionnaire (baseline to follow up at 12 months) [ Time Frame: Baseline to follow up at 12 months. ]
Central Contacts
- Anna Spångeus, Ass Prof MD+46-10-1030000
- Johanna Wibault, PhD+46-10-1030000
Related Studies
- Mode of Exercise and Bone Biomarkers in Older VeteransRecruiting · VA Office of Research and Development · Aurora, Colorado
- Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity ArthroplastyRecruiting · Johns Hopkins University · Columbia, Maryland
- Studying Patient Experiences in Osteoporosis Clinical TrialsNot Yet Recruiting · Power Life Sciences Inc. · San Francisco, California
- EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI TherapyPHASE3 · Recruiting · University of Texas Southwestern Medical Center · Dallas, Texas